New research just presented at #GI25: STARTER-NET trial shows everolimus + lanreotide more than doubles PFS vs everolimus monotherapy among pts w/ aggressive GEP-NETs:#ASCODailyNews #GICSM
#GI25 #ASCODailyNews #GICSM